考科藍臺灣 - Cochrane Taiwan,
【最新考科藍文獻回顧結果翻譯】 血壓高或有高血壓疾病可能會引起心臟病發作和中風。新一類藥物「腎素抑制劑」被用來治療高血壓。Aliskiren是目前唯一在這類腎素抑制劑中,經研究並被核准用來治療高血壓的藥物。 本篇文獻回顧探討aliskiren相較於安慰劑…
【最新考科藍文獻回顧結果翻譯】 血壓高或有高血壓疾病可能會引起心臟病發作和中風。新一類藥物「腎素抑制劑」被用來治療高血壓。Aliskiren是目前唯一在這類腎素抑制劑中,經研究並被核准用來治療高血壓的藥物。 本篇文獻回顧探討aliskiren相較於安慰劑…
#Cochrane review Blood pressure lowering efficacy of aliskiren now avail in Chinese: http://ow.ly/ytEI30faUUc #CochraneEvidence…
#Cochrane review Blood pressure lowering efficacy of aliskiren now avail in Chinese: http://ow.ly/ytEI30faUUc #CochraneEvidence…
#Cochrane review Blood pressure lowering efficacy of aliskiren now avail in Chinese: http://ow.ly/ytEI30faUUc #CochraneEvidence…
#Cochrane review Blood pressure lowering efficacy of aliskiren now avail in Chinese: http://ow.ly/ytEI30faUUc #CochraneEvidence…
#Cochrane review Blood pressure lowering efficacy of aliskiren now avail in Chinese: http://ow.ly/ytEI30faUUc #CochraneEvidence…
#Cochrane review Blood pressure lowering efficacy of aliskiren now avail in Chinese: http://ow.ly/ytEI30faUUc #CochraneEvidence …
UPDATED Cochrane review: Blood pressure lowering efficacy of renin inhibitors for primary hypertension: http://ow.ly/vFIc30bl…
A new Cochrane Review has been published, which highlights the dangerous problem of having incomplete access to data about…